These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33852927)

  • 21. A novel three dimensional imaging method for the measurement of area in vitiligo and chemical leukoderma.
    Hayashi M; Okamura K; Araki Y; Suzuki M; Tanaka T; Abe Y; Nakano S; Yoshizawa J; Hozumi Y; Inoie M; Suzuki T
    J Dermatol Sci; 2016 Nov; 84(2):219-221. PubMed ID: 27576766
    [No Abstract]   [Full Text] [Related]  

  • 22. Cosmetic camouflage as an adjuvant to vitiligo therapies: Effect on quality of life.
    Bassiouny D; Hegazy R; Esmat S; Gawdat HI; Ahmed Ezzat M; Tawfik HA; Hegazy AA; Ibrahim S
    J Cosmet Dermatol; 2021 Jan; 20(1):159-165. PubMed ID: 32406129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociated depigmentation in vitiligo; significance and therapeutic implications.
    PEGUM JS
    Br J Dermatol; 1955 Oct; 67(10):348-50. PubMed ID: 13260554
    [No Abstract]   [Full Text] [Related]  

  • 24. The Double Strike Hypothesis of the vitiligo pathomechanism: new approaches to vitiligo and melanoma.
    Michelsen D
    Med Hypotheses; 2010 Jan; 74(1):67-70. PubMed ID: 19748188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod.
    Mashiah J; Brenner S
    Clin Exp Dermatol; 2008 Jan; 33(1):74-6. PubMed ID: 17979992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The 308 nm Excimer laser : Treatment of vitiligo and hypopigmentation].
    Fritz K; Salavastru C
    Hautarzt; 2018 Jan; 69(1):44-47. PubMed ID: 29294169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plateletcrit values may not be higher in patients with vitiligo.
    Beyan C; Beyan E
    Arch Dermatol Res; 2021 Aug; 313(6):499-500. PubMed ID: 33564893
    [No Abstract]   [Full Text] [Related]  

  • 28. Social Anxiety and Quality of Life in Vitiligo and Acne Patients with Facial Involvement: A Cross-Sectional Controlled Study.
    Salman A; Kurt E; Topcuoglu V; Demircay Z
    Am J Clin Dermatol; 2016 Jun; 17(3):305-11. PubMed ID: 26818062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with Modified Heat Shock Protein Repigments Vitiligo Lesions in Sinclair Swine.
    Frisoli ML; Harris JE
    J Invest Dermatol; 2018 Dec; 138(12):2505-2506. PubMed ID: 30466536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Unilateral systematized vitiligo or achromic nevus].
    CARO-PATON T
    Actas Dermosifiliogr; 1950 May; 41(8):717-23. PubMed ID: 14770946
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of the quality of life of pediatric patients with the major chronic childhood skin diseases.
    Manzoni AP; Pereira RL; Townsend RZ; Weber MB; Nagatomi AR; Cestari TF
    An Bras Dermatol; 2012; 87(3):361-8. PubMed ID: 22714749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukoderma centrifugum acquisitum and vitiligo.
    KANEE B
    AMA Arch Derm; 1957 Jun; 75(6):873-4. PubMed ID: 13423897
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible mechanisms of hypopigmentation in lichen sclerosus.
    Carlson JA; Grabowski R; Mu XC; Del Rosario A; Malfetano J; Slominski A
    Am J Dermatopathol; 2002 Apr; 24(2):97-107. PubMed ID: 11979069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitiligo-like depigmentation patterns in patients receiving immunotherapy for metastatic melanoma.
    Zottarelli F; Giorgione R; Gironi LC; Farinelli P; Sponghini AP; Rondonotti D; Savoia P
    Ital J Dermatol Venerol; 2021 Feb; 156(1):97-99. PubMed ID: 30350560
    [No Abstract]   [Full Text] [Related]  

  • 35. Quality of life impairment amongst persons living with vitiligo using disease specific vitiligo quality of life index: A Nigerian perspective.
    Abdullahi U; Mohammed TT; P Musa BO
    Niger Postgrad Med J; 2021; 28(3):169-174. PubMed ID: 34708702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of Google search interest for vitiligo with race and ethnicity: a nationwide, population-based study.
    Khanna P; Riddle AO; Ahmed AM
    Int J Dermatol; 2023 Apr; 62(4):e260-e261. PubMed ID: 35959524
    [No Abstract]   [Full Text] [Related]  

  • 37. Views and Beliefs of Vitiligo Patients in Online Discussion Forums: A Qualitative Study.
    Gadarowski MB; Bashyam AM; McMichael AJ; Feldman SR
    Cutis; 2022 Jan; 109(1):49-53. PubMed ID: 35180057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool.
    Salzes C; Abadie S; Seneschal J; Whitton M; Meurant JM; Jouary T; Ballanger F; Boralevi F; Taieb A; Taieb C; Ezzedine K
    J Invest Dermatol; 2016 Jan; 136(1):52-8. PubMed ID: 26763423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study.
    Canu D; Shourick J; Andreu N; Gey A; Ballanger-Désolneux F; Barailler H; Boniface K; Ezzedine K; Seneschal J
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e676-e679. PubMed ID: 34013570
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of 'not relevant' responses on the Dermatology Life Quality Index (DLQI) and the DLQI-R scoring modification among Indian patients with vitiligo.
    Gupta V; Taneja N; Sati HC; Sreenivas V; Ramam M
    Br J Dermatol; 2021 Jan; 184(1):168-169. PubMed ID: 32730641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.